| Genomic aspects of NAFLD pathogenesis A Naik, D Rozman Genomics 102 (2), 84-95, 2013 | 112 | 2013 |
| Molecular interactions between NAFLD and xenobiotic metabolism A Naik, A Belič, UM Zanger, D Rozman Frontiers in genetics 4, 2, 2013 | 79 | 2013 |
| The obesity paradox in cancer, tumor immunology, and immunotherapy: potential therapeutic implications in triple negative breast cancer A Naik, AM Monjazeb, J Decock Frontiers in immunology 10, 1940, 2019 | 75 | 2019 |
| PRAME promotes epithelial-to-mesenchymal transition in triple negative breast cancer G Al-Khadairi, A Naik, R Thomas, B Al-Sulaiti, S Rizly, J Decock Journal of translational medicine 17, 1-14, 2019 | 59 | 2019 |
| Neuropilin-1 promotes the oncogenic Tenascin-C/integrin β3 pathway and modulates chemoresistance in breast cancer cells A Naik, A Al-Yahyaee, N Abdullah, JE Sam, N Al-Zeheimi, MW Yaish, ... BMC cancer 18, 1-14, 2018 | 54 | 2018 |
| Neuropilin-1 associated molecules in the blood distinguish poor prognosis breast cancer: a cross-sectional study A Naik, N Al-Zeheimi, CS Bakheit, M Al Riyami, A Al Jarrah, ... Scientific reports 7 (1), 3301, 2017 | 46 | 2017 |
| Transcription factors: The fulcrum between cell development and carcinogenesis Z Islam, AM Ali, A Naik, M Eldaw, J Decock, PR Kolatkar Frontiers in oncology 11, 681377, 2021 | 32 | 2021 |
| Lactate metabolism and immune modulation in breast cancer: a focused review on triple negative breast tumors A Naik, J Decock Frontiers in Oncology 10, 598626, 2020 | 28 | 2020 |
| Age, disease severity and ethnicity influence humoral responses in a multi-ethnic COVID-19 cohort M Smith, HB Abdesselem, M Mullins, TM Tan, AJM Nel, MAY Al-Nesf, ... Viruses 13 (5), 786, 2021 | 23 | 2021 |
| SteatoNet: the first integrated human metabolic model with multi-layered regulation to investigate liver-associated pathologies A Naik, D Rozman, A Belič PLoS computational biology 10 (12), e1003993, 2014 | 23 | 2014 |
| Identification of two HLA-A* 0201 immunogenic epitopes of lactate dehydrogenase C (LDHC): potential novel targets for cancer immunotherapy R Thomas, H Shaath, A Naik, SM Toor, E Elkord, J Decock Cancer immunology, immunotherapy 69, 449-463, 2020 | 21 | 2020 |
| Analysis of the steady-state relations and control-algorithm characterisation in a mathematical model of cholesterol biosynthesis A Belič, J Ačimovič, A Naik, M Goličnik Simulation Modelling Practice and Theory 33, 18-27, 2013 | 18 | 2013 |
| Cancer testis antigen PRAME: An anti‐cancer target with immunomodulatory potential A Naik, R Thomas, G Al‐Khadairi, R Bacha, W Hendrickx, J Decock Journal of Cellular and Molecular Medicine 25 (22), 10376-10388, 2021 | 15 | 2021 |
| Targeting of lactate dehydrogenase C dysregulates the cell cycle and sensitizes breast cancer cells to DNA damage response targeted therapy A Naik, J Decock Molecular Oncology 16 (4), 885-903, 2022 | 14 | 2022 |
| Neoadjuvant Chemotherapy Alters Neuropilin-1, PlGF, and SNAI1 Expression Levels and Predicts Breast Cancer Patients Response N Al-Zeheimi, A Naik, CS Bakheit, M Al Riyami, A Al Ajarrah, S Al Badi, ... Frontiers in Oncology 9, 323, 2019 | 14 | 2019 |
| Immune-related 3-lncRNA signature with prognostic connotation in a multi-cancer setting S Sherif, R Mall, H Almeer, A Naik, A Al Homaid, R Thomas, J Roelands, ... Journal of Translational Medicine 20 (1), 442, 2022 | 6 | 2022 |
| Cancer testis antigens in cancer: Recent developments as cancer biomarkers and therapeutic targets A Naik, J Yeong, J Decock Frontiers in Oncology 12, 1075329, 2022 | 2 | 2022 |
| Commentary: Cancer-testis antigen lactate dehydrogenase C4 as a novel biomarker of male infertility and cancer A Naik, J Decock Frontiers in Oncology 13, 1115620, 2023 | 1 | 2023 |
| Construction of SteatoNet: a metabolic network to investigate NAFLD-related hepatic steatosis A Naik | 1 | 2013 |
| Analysis of the Cholesterol Biosynthesis Feedback Control and its Consequences for the Hypercholesteremia Treatment Strategies ABA Naik IFAC Proceedings Volumes 45 (2), 624-628, 2012 | 1 | 2012 |
